Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week

Vuk Zdinjak

1061 posts
Group By Ticker
Sort By
Newest | Oldest
Read More
2 minute read
  • Cannabis
  • Markets
  • News
  • Penny Stocks
  • Small Cap

Tilray’s Manitoba Harvest Expands Whole Foods Market Distribution

By Vuk Zdinjak
April 4, 7:42 AM
Manitoba Harvest, a wholly-owned subsidiary of Tilray Brands, Inc. (NASDAQ: TLRY) (TSX:TLRY), debuts the brand’s first Regenerative Organic Certified (ROC) Hemp Hearts exclusively at select Whole Foods Market stor

TLRY

Read More
2 minute read
  • Cannabis
  • Earnings
  • Markets
  • News
  • Penny Stocks

Goodness Growth FY22 Revenue Increases 37.1% To $74.6M, Here Are The Details

By Vuk Zdinjak
April 3, 11:03 AM
Goodness Growth Holdings, Inc. (OTCQX: GDNSF) (CSE:GDNS) FY 2022 revenue was $74.6 million, an increase of 37.1% compared to $54.4 million in FY 2021.

CSE:GDNS

Read More
2 minute read
  • Cannabis
  • Earnings
  • Markets
  • News
  • Penny Stocks

Flora Growth Stock Trading Lower On 314% Annual Revenue Growth

By Vuk Zdinjak
April 3, 10:29 AM
Flora Growth Corp. (NASDAQ: FLGC) FY 2022 revenue was $37.2 million, a 314% increase year-over-year. This was primarily driven by the House of Brands businesses. Q4 2022, revenue was $11.5 million, a 7% sequential increase from Q3 2022.

FLGC

Read More
2 minute read
  • Cannabis
  • Markets
  • News
  • Penny Stocks

Playboy And Cannabis Accessories Brand Team Up To ‘Destigmatize The Use Of Cannabis By Women’

By Vuk Zdinjak
April 3, 9:48 AM
Sackville & Co., a design-centric cannabis accessories brand, announced its collaboration with Playboy, the globally-recognized, lifestyle brand owned by PLBY Group Inc. (NASDAQ: PLBY) Launching April 20th, the two-piece collaboration will include

PLBY

Read More
2 minute read
  • Cannabis
  • Earnings
  • Markets
  • News
  • Penny Stocks

Rubicon Organics FY22 Revenue Grows 57% To $26.4M, What About Adjusted EBITDA?

By Vuk Zdinjak
April 3, 9:14 AM
Rubicon Organics Inc. (OTCQX: ROMJF) (TSXV:ROMJ) achieved a record net revenue in FY 2022 of CA$35.5 million ($26.4 million), a 57% increase compared t

ROMJF

Read More
1 minute read
  • Cannabis
  • Earnings
  • Markets
  • News
  • Penny Stocks

Avicanna FY22 Revenue Grows 24%, Here Is What You Need To Know

By Vuk Zdinjak
April 3, 8:36 AM
Avicanna Inc. (TSX:AVCN) (OTCQX: AVCNF) (FSE:0NN) total fiscal 2022 revenue of CA$4 million representing growth of 24% from CA$3.3 million in fiscal 2021.

AVCNF

Read More
2 minute read
  • Cannabis
  • Earnings
  • Markets
  • News
  • Penny Stocks

InterCure Shares Soar On FY22 Record Revenue Of $108.3M

By Vuk Zdinjak
April 3, 8:15 AM
InterCure Ltd. (NASDAQ: INCR) (TSX:INCR.U) (TASE:INCR) (dba Canndoc) fiscal year 2022 revenue was NIS 388.7 million ($108.3 million), an increase of 77% compared to NIS 219.7 million in 2021.

INCR

Read More
2 minute read
  • Cannabis
  • Earnings
  • Markets
  • News
  • Penny Stocks

MediPharm Labs FY22 Revenue Grows Slightly To $16.3M

By Vuk Zdinjak
March 31, 11:14 AM
MediPharm Labs Corp. (TSX:LABS) (OTCQX: MEDIF) (FSE:MLZ) FY 2022 revenue was CA$22.1 million ($16.3 million), an increase of 1.8% compared to CA$21.7 million in FY 2021.

MEDIF

Read More
2 minute read
  • Cannabis
  • Earnings
  • Markets
  • News
  • Penny Stocks

4Front Ventures FY22 Revenue Grows 13%, What About Net Loss?

By Vuk Zdinjak
March 31, 10:47 AM
4Front Ventures Corp. (CSE:FFNT) (OTCQX: FFNTF) FY 2022 revenue increased 13% year-over-year to $118.5 million. FY 2022 Highlights Gross profit was $41.1 million compared to $49.4 million in FY 2021.

CSE:FFNT

Read More
2 minute read
  • Cannabis
  • Earnings
  • Markets
  • News
  • Penny Stocks

Auxly FY22 Net Revenue Grows 13%, What About Adjusted EBITDA?

By Vuk Zdinjak
March 31, 10:31 AM
Auxly Cannabis Group Inc. (TSX:XLY) (OTCQB: CBWTF) 2022 total net revenue was CA$94.4 million, an increase of CA$10.6 million or 13% compared to 2021.

CBWTF

Posts pagination

Previous 1 … 46 47 48 … 107 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service